Not Signed In - New Data Support AlphaVax's Vaccine For CMV
Tue, 20 Feb 2007 08:00 AM EST
... AlphaVax Inc.'s novel alphavaccine technology has been shown to be effective in generating protection against congenital cytomegalovirus (CMV) disease in a preclinical study published in the March 15, 2007 issue of the Journal of Infectious Disease, the on-line version of which was distributed on February 14. [click link for full article] ...
Related Topics
- Cmv
- Data & Statistics
- Data Analysis
- National Data
- Vaccine
- Polio Vaccine & Cancer
- Polio Vaccine
- Polio Vaccine & Origin of HIV/AIDS
- Vaccine Safety: Data-Sharing Process
- Social Support
- Support Groups
- Vaccine Side Effects
- MMR Vaccine & (Asceptic) Meningitis
- Smallpox Vaccine
- Chickenpox Vaccine
- Mining
- Hepatitis A Vaccine
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis B Vaccine
- Pneumococcal Vaccine
email this page
print this page
bookmark this page
feedback on this page
